Advertisement

Topics

Cilag AG Company Profile

23:52 EDT 18th September 2018 | BioPortfolio

Nil

Location

Hochstrasse 201
Schaffhausen
Schweiz
8205
Switzerland

Contact

Phone: 41 (52) 630 9111
Fax: 41 (52) 630 9444
Email: cilag@cilch.jnj.com


News Articles [3 Associated News Articles listed on BioPortfolio]

Probi & Cilag sign long-term agreement to develop probiotic product

Swedish bioengineering company, Probi, has signed a long-term agreement with Cilag, which is a member of the Johnson & Johnson family of companies, for the development of a probiotic product.

20152023 World Pyrogallol Acid Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 25022018] Prices from USD $2800

SummaryThis report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and en...

20152023 World 5Aminosalicylic Acid Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 23022018] Prices from USD $2800

SummaryThis report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and en...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Stelara [Janssen Biotech, Inc.]

These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA (ustekinumab) Injection, for subcutaneous useIn...

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma.

In recent years, the anti-CD38 monoclonal antibody daratumumab (Darzalex; Janssen-Cilag Pty Ltd) has been shown to be highly efficacious in relapsed and refractory multiple myeloma, with the final res...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Study to Evaluate the Efficacy and Safety of HX 575 vs ERYPO® for the Treatment of Anemia in Hemodialysis Patients

This is a double-blind, randomized, multicenter, parallel-group, equivalence study involving about 462 clinically stable hemodialysis patients aged 18 years or above suffering from anemia ...

Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients

This is a randomized, double-blind, multicenter clinical phase III study involving about 105 cancer patients aged >18 years who are receiving palliative chemotherapy and who are suffering ...

Action of the Vidaza on the Atrial Fibrillation

Genomic studies on atrial fibrillation patients have identified polymorphisms in regions surrounding the PITX2 gene, suggesting it could be the locus responsible for atrial fibrillation. T...

Companies [7 Associated Companies listed on BioPortfolio]

Janssen-Cilag EMEA, EMHF, ESHA & ISG

Janssen-Cilag EMEA, a division of Janssen Pharmaceutica N.V., is a research-based pharmaceutical company that develops and markets innovative, high-quality pharmaceutical products and services aim...

Cilag AG

Nil

Janssen-Cilag AG

NIL

Janssen-Cilag Farmacéutica

NIL

Janssen-Cilag International NV

More Information about "Cilag AG" on BioPortfolio

We have published hundreds of Cilag AG news stories on BioPortfolio along with dozens of Cilag AG Clinical Trials and PubMed Articles about Cilag AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cilag AG Companies in our database. You can also find out about relevant Cilag AG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record